You can eat more protein on this diet: Atkins is designed to help you lose weight by following a low-carb diet that prioritizes eating more protein than keto—and protein is important when it ...

The company reported positive Phase 1 results for TNX-1500, an anti-CD40L monoclonal antibody designed to prevent kidney transplant rejection and address autoimmune disorders.

The Department of Health and Human Services and the Food and Drug Administration announced on Tuesday a series of measures to phase out eight artificial food dyes and colorings from America's food ...

The Trump administration announced its intention to phase out synthetic dyes used to enhance color in common foods like candy and cereals. At a press conference Tuesday, Health and Human Services ...

Health and Human Services Secretary Robert F. Kennedy Jr. and the Food and Drug Administration announced a plan to phase out petroleum-based dyes in food by the end of 2026.

U.S. health officials on Tuesday said they would phase out petroleum-based artificial colors in the nation’s food supply, potentially triggering an ingredients overhaul for scores of brightly… ...

RFK Plans To Phase Out Food Dyes by 2026 No clips available in the subcollection. Major changes are coming to the nation's food supply. Yesterday the Health and Human Services secretary and FDA ...

Davenport Community School District continues to plan for the future of the district’s facilities. That includes the district’s long-range facilities plan which is nearing the end of Phase 1 ...

Objective Low-carbohydrate diets may be useful for weight loss. Diets high in vegetable proteins and oils may reduce the risk of coronary heart disease. The main objective was to determine the longer ...

The Atkins diet recommends a limit of 20g of carbohydrate each day for the initial 14-day induction phase. This is a very small amount; for example a banana contains about 22g.

Cassava Sciences, Inc. has announced the expected release of topline data from its Phase 3 REFOCUS-ALZ study on simufilam for mild-to-moderate Alzheimer's disease, anticipated in late Q1 or early ...